SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-029340
Filing Date
2022-05-24
Accepted
2022-05-24 17:24:31
Documents
15
Period of Report
2022-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160368-8k_augmedix.htm   iXBRL 8-K 42495
2 OPEN MARKET SALE AGREEMENTSM, DATED AS OF MAY 24, 2022, BY AND BETWEEN AUGMEDIX, ea160368ex1-1_augmedix.htm EX-1.1 213241
3 OPINION OF MORRISON & FOERSTER LLP ea160368ex5-1_augmedix.htm EX-5.1 9477
4 GRAPHIC ex5-1_001.jpg GRAPHIC 2457
  Complete submission text file 0001213900-22-029340.txt   505305

Data Files

Seq Description Document Type Size
5 XBRL LABEL FILE augx-20220524_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE augx-20220524_pre.xml EX-101.PRE 22595
7 XBRL SCHEMA FILE augx-20220524.xsd EX-101.SCH 3033
9 EXTRACTED XBRL INSTANCE DOCUMENT ea160368-8k_augmedix_htm.xml XML 3718
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 22958171
SIC: 7389 Services-Business Services, NEC